New eye injection aims to slow vision loss in rare disease
Disease control
Not yet recruiting
This early-stage trial tests a new medicine called ZM-02, given as an injection into the eye, for people with advanced retinitis pigmentosa—a condition that causes gradual vision loss. The study includes 21 participants aged 6 to 60 and compares the injection to a sham procedure …
Phase: PHASE1, PHASE2 • Sponsor: Zhongmou Therapeutics • Aim: Disease control
Last updated May 01, 2026 15:57 UTC